Filing Details

Accession Number:
0001246360-13-004103
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-22 17:07:08
Reporting Period:
2013-08-21
Filing Date:
2013-08-22
Accepted Time:
2013-08-22 17:07:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64670 Medtronic Inc MDT Electromedical & Electrotherapeutic Apparatus (3845) 410793183
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1324953 James H Dallas 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Srvp Quality, Operations, It No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-21 8,352 $35.92 97,082 No 4 M Direct
Common Stock Acquisiton 2013-08-21 8,873 $37.53 105,955 No 4 M Direct
Common Stock Acquisiton 2013-08-21 11,468 $34.88 117,423 No 4 M Direct
Common Stock Acquisiton 2013-08-21 10,306 $38.81 127,729 No 4 M Direct
Common Stock Disposition 2013-08-21 36,256 $52.82 91,473 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-08-21 8,352 $0.00 8,352 $35.92
Common Stock Employee Stock Option (right to buy) Disposition 2013-08-21 8,873 $0.00 8,873 $37.53
Common Stock Employee Stock Option (right to buy) Disposition 2013-08-21 11,468 $0.00 11,468 $34.88
Common Stock Employee Stock Option (right to buy) Disposition 2013-08-21 10,306 $0.00 10,306 $38.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-08-03 2019-08-03 No 4 M Direct
8,873 2011-08-02 2020-08-02 No 4 M Direct
22,936 2012-08-01 2021-08-01 No 4 M Direct
30,921 2013-07-30 2022-07-30 No 4 M Direct
Footnotes
  1. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  2. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.57 to $52.95 inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes to this Form 4.